China National Accord Medicines Corporation Ltd. (200028.SZ)
- Previous Close
14.66 - Open
14.54 - Bid 14.58 x --
- Ask 14.62 x --
- Day's Range
14.49 - 14.62 - 52 Week Range
12.25 - 16.81 - Volume
117,230 - Avg. Volume
238,539 - Market Cap (intraday)
19.912B - Beta (5Y Monthly) --
- PE Ratio (TTM)
4.64 - EPS (TTM)
3.15 - Earnings Date --
- Forward Dividend & Yield 0.90 (6.17%)
- Ex-Dividend Date Jun 1, 2023
- 1y Target Est
--
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. it offers drugs, medical equipment, cargo transportation, warehousing, loading and unloading, glass instruments, cosmetics, sales of daily necessities, other business services, other professional consulting, and self-management services; agent services; import and export of various commodities and technologies; and house leasing services. The company is also involved in the import and export of proprietary Chinese medicines, chemical preparations, antibiotics, biochemical drugs, biological preparations, diagnostic drugs, therapeutic and diagnostic biological products, stereotyped packaged foods, chemical products, and self-management and agency of various commodities and technologies. In addition, it engages in the retail and distribution of medical devices, as well as wholesale and retail of health supplies, etc. The company was formerly known as Shenzhen Health Mineral Water Corp., Ltd. The company was incorporated in 1993 and is headquartered in Shenzhen, China. China National Accord Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co., Ltd.
www.szaccord.com.cn39,449
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 200028.SZ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 200028.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 200028.SZ
Valuation Measures
Market Cap
19.45B
Enterprise Value
20.30B
Trailing P/E
4.63
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.10
Price/Book (mrq)
0.42
Enterprise Value/Revenue
0.27
Enterprise Value/EBITDA
7.55
Financial Highlights
Profitability and Income Statement
Profit Margin
2.14%
Return on Assets (ttm)
2.89%
Return on Equity (ttm)
9.41%
Revenue (ttm)
75.88B
Net Income Avi to Common (ttm)
1.63B
Diluted EPS (ttm)
3.15
Balance Sheet and Cash Flow
Total Cash (mrq)
5.72B
Total Debt/Equity (mrq)
30.39%
Levered Free Cash Flow (ttm)
492.54M
Research Analysis: 200028.SZ
Company Insights: 200028.SZ
200028.SZ does not have Company Insights